Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Andrea Eisen"'
Autor:
Andrew T. Yan, Craig C. Earle, Maureen E. Trudeau, Kelvin K. W. Chan, Inna Y. Gong, Andrea Eisen
Publikováno v:
Breast Cancer Research and Treatment. 181:155-165
Little data exist for comparing cardiac safety and survival outcomes of trastuzumab/pertuzumab or ado-T emtansine (TDM1) in metastatic breast cancer (MBC) patients enrolled in randomized clinical trial (RCT) vs the real-world. This was a retrospectiv
Autor:
Olivia Moran, Kelly A. Metcalfe, Kristina M. Blackmore, Ophira Ginsburg, Andrea Eisen, Joanne Kotsopoulos, Martin J. Yaffe, Rochelle Demsky, Steven A. Narod, Seema Panchal, Julia A. Knight, Kevin Zbuk
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-12 (2019)
BMC Cancer
BMC Cancer
Background Mammographic density is one of the strongest risk factors for breast cancer. In the general population, mammographic density can be modified by various exposures; whether this is true for women a strong family history is not known. Thus, w
Autor:
Eva Grunfeld, Jane K Mills, Derek Muradali, Andrea Eisen, Matthew Castelo, Adena S Scheer, Angela E Schellenberg, Zachary Brown
Publikováno v:
The breast journalREFERENCES. 27(5)
Background: The Ontario Breast Screening Program was expanded in 2011 to offer annual MRI and mammography to women with high-risk genetic mutations (e.g., BRCA1/2) and women with strong family histories and ≥25% estimated lifetime risk of breast ca
Publikováno v:
Current Oncology. 25:176-180
Background Despite the fact that heterozygosity for a pathogenic ATM variant is present in 1%–2% of the adult population, clinical guidelines to inform physicians and genetic counsellors about optimal management in that population are lacking. Meth
Autor:
Courtney R. Smith, Andrea Eisen, Anna M. Chiarelli, Erin B. Kennedy, Claire M. B. Holloway, Derek Muradali
Publikováno v:
Preventive Medicine. 103:70-75
There is a large and growing population of women who have a personal history of breast cancer (PHBC). This systematic review was undertaken to explore the outcomes of surveillance mammography in breast cancer survivors, and to examine the evidence fo
Autor:
Antonis C. Antoniou, Douglas F. Easton, Jean-Yves Masson, Michel Dorval, Samantha Fienberg, Nicole Mittmann, Meghan J. Walker, Jennifer D. Brooks, Michael Wolfson, Irene L. Andrulis, David E. Goldgar, Hermann Nabi, Jean-Sébastien Paquette, Sean V. Tavtigian, Bartha Maria Knoppers, Anna M. Chiarelli, Jacques Simard, Yann Joly, Peter Devilee, Nora Pashayan, Arnaud Droit, Tracy Stockley, Aisha Lofters, Rita K. Schmutzler, Laurence Eloy, Jocelyne Chiquette, Eric Hahnen, Andrea Eisen, Philippe Després
Publikováno v:
Journal of Personalized Medicine, 11(6). MDPI
Journal of Personalized Medicine
Journal of Personalized Medicine, Vol 11, Iss 511, p 511 (2021)
Journal of Personalized Medicine
Journal of Personalized Medicine, Vol 11, Iss 511, p 511 (2021)
Early detection of breast cancer through screening reduces breast cancer mortality. The benefits of screening must also be considered within the context of potential harms (e.g., false positives, overdiagnosis). Furthermore, while breast cancer risk
Autor:
Shana J. Kim, Andrea Eisen, Anna Zuchniak, Young-In Kim, Steven A. Narod, Kyoung-Jin Sohn, Mohammad R. Akbari, R. Demsky, Jan Lubinski, Joanne Kotsopoulos
Publikováno v:
The American Journal of Clinical Nutrition. 104:671-677
Background B vitamins [vitamins B-6, B-9 (folate), and B-12] play important roles in nucleotide biosynthesis and biological methylation reactions, aberrancies of which have all been implicated in carcinogenesis. In the general population, evidence ha
Autor:
T Mancuso, T Graham, Karen Ott, Paul Hewitt, Andrea Eisen, J Lorentz, M Emmerson, Jacques Raphael
Publikováno v:
Cancer Research. 76:P6-10
Background Women with identified BRCA1/2 mutation have a substantially increased risk of developing several types of cancer, mainly breast and ovarian, during their lifetime. Management options included close surveillance, chemoprevention and prophyl
Autor:
Tuya Pal, Jan Lubinski, Jacek Gronwald, Charis Eng, Andrea Eisen, Jeffrey N. Weitzel, Steven A. Narod, William D. Foulkes, Peter Ainsworth, Susan L. Neuhausen, Joanne Kotsopoulos, Leigha Senter, Nadine Tung, Henry T. Lynch, Christian F. Singer, Ping Sun
Publikováno v:
Breast cancer research and treatment. 171(2)
In the general population, an early age at first full-term birth confers protection against the risk of developing breast cancer. The relationship between age at first birth and breast cancer risk is not clear for women with a mutation in the BRCA1 o
Autor:
Ellen Warner, Sofia Torres, Mark Hew‐Shue, Sonal Gandhi, Sunil Verma, Kathleen I. Pritchard, Teresa M. Petrella, Andrea Eisen, Calvin Chao, Maureen E. Trudeau
Background The 21-gene Recurrence Score (RS) assay is only reimbursed in Ontario for node-negative and micrometastatic node-positive (N+) early-stage breast cancer (EBC). We carried out a prospective study to evaluate the impact of the assay on treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c626a989806dd322d20ee9cb2b29d980
https://europepmc.org/articles/PMC6058344/
https://europepmc.org/articles/PMC6058344/